- Report ID: BMRC 530 | Number of pages: 198 | Publish Date: Jan 2020
Status: Published | Category: Healthcare | Delivery Timeline:
Smart Inhalers Market: Global Size, Trends, Competitive, and Historical & Forecast Analysis, 2019-2025– Advanced technological requirements in healthcare products and lack of awareness about treatment of pulmonary diseases and rising number of patients affected by bronchospasm are the major factors driving the market growth.
Smart Inhalers Market is valued around USD 31.92 Million in 2018 and expected to reach USD 740.5 Million by 2025 with CAGR of 56.7% over the forecast period.
Smart inhalers are inhalers which can be connected to multiple devices to take the patients' health updates on daily basis especially for the people who have respiratory diseases like asthma and COPD these diseases. It has sensors which reminds about the daily dosage and how much can actually take. As technology is getting smarter it’s getting useful in healthcare products too. However people who are using different medications to control asthma, it provides multi meditational permissions for them also. Smart inhalers are one of the examples of smart technology. Now patients who are suffering from bronchospasm, it is useful for them to poise their dosage. Actually the condition of today is people are very much known about diseases through smartphones, browsers allow the users to browse and search anything and it gives brief information about what users search for. Now phones tell the users where they are and what’s in their vicinity, so the people are very much relying on their phones. So, companies which make healthcare products are stepping ahead towards the new era of technology. Smart inhalers can be used connecting laptops, computers and mobiles through bluetooth. It is a multifunctional device which allows these devices to connect and it inform the limit of daily dosage, how much dosage left and what’s the condition of your health.
Global smart inhalers market is segmented on the basis of product type, application, indication and region & country level. On the basis of product type, the market is segmented into inhalers and nebulizers. On the basis of application, the market is segmented into patients and research and development. On the basis of indication, the market is segmented into asthma and COPD.
The regions covered in this Smart Inhalers Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Smart Inhalers is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Smart Inhalers Market report covers prominent players like market players Teva Pharmaceutical Industries Ltd., Vectura Group plc., Boehringer Ingelheim GmbH, AstraZeneca plc, Propeller Health, OPKO Health, Inc., Adherium Limited, Novartis AG, GlaxoSmithKline plc and others.
Advance technological requirement in healthcare products is one of the drivers of this market. Nowadays people and technology is getting way more advanced than traditional techniques. In the scenario of pulmonary diseases many people are still unaware about its symptoms. However the stats published by World Health Organization (WHO) on current affected people of asthma are around 235 million worldwide. This is not an ordinary number. It is happening due to lack of awareness about asthma and COPD among people and leading to the increasing number of incidences of these diseases and drives the demand for smart inhalers. In addition, increasing adoption IoT devices in healthcare is also expected to supplement the market growth. Population and pollution are two main factors which are rapidly growing. With increasing population there are several diseases coming to know. Some of them can be diagnosed within few days and some can be diagnosed for limited period. For example bronchospasm, this is chronic disease and it is not for limited period, it affects people for life long. This disease blocks the lines from which the air flows in body. Rising number of patients affected by bronchospasm are some factors driving the demand for smart inhalers. Availability of the substitutive products and high cost for the product can be the restrain for the market of smart inhalers. Moreover, an untapped market can be an opportunity for the further growth of the market.
The smart inhalers market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. North America is expected to dominate the global smart inhalers market. Around 25 million Americans have asthma in which 7.7% of adults and 8.2% of children have asthma. Behind every 13 people 1 person has asthma and the number is increasing rapidly. High awareness about the chronic diseases and the benefits of smart inhalers is one of the major factors driving the market growth in this region. Europe is second largest region of asthma affected people around 30 million of adults and children’s.
Key Benefits for Market Report–
By Product Type:
By Application Type:
By Indication Type:
By Regional & Country:
Interested in this report?
Smart Inhalers Market Size, Share, Business Stats, Growth perspective and Forecast 2020-2025